British American Tobacco stock initiated with Buy rating at Jefferies

Published 09/07/2025, 06:32
British American Tobacco stock initiated with Buy rating at Jefferies

Investing.com - Jefferies initiated coverage on British American Tobacco (NYSE:BTI) with a Buy rating and set a price target of GBP48.00, according to a research note released Wednesday. The company, currently valued at $104.7 billion, has demonstrated strong momentum with a 36.65% return year-to-date.

The investment firm identified British American Tobacco as its top pick in the tobacco sector, citing the company’s improving profitability in its traditional combustibles business, which supports its transition toward smoke-free products.

Jefferies highlighted the company’s "strong foothold" in smoke-free products with potential for further expansion, alongside a strengthening balance sheet and substantial cash returns to shareholders.

The research note pointed out that British American Tobacco currently trades at a 35% discount compared to the wider tobacco sector, a gap that Jefferies believes should narrow in the future.

British American Tobacco, which trades on both the London Stock Exchange (LON:LSEG) (BATS:LN) and the New York Stock Exchange, has been expanding its portfolio beyond traditional cigarettes as consumer preferences shift toward alternative nicotine products.

In other recent news, British American Tobacco has completed the sale of a 2.5% stake in Indian conglomerate ITC (NSE:ITC) for approximately $1.42 billion, exceeding initial expectations. The sale involved 313 million shares and was executed through an accelerated book-build process. The company plans to use the proceeds to expand its share buyback program by an additional 200 million pounds, bringing the total buyback amount to 1.1 billion pounds for the year. In a separate development, Deutsche Bank (ETR:DBKGn) raised its price target for British American Tobacco shares to £38.00, maintaining a Buy rating, following a positive revenue projection for the first half of 2025.

Additionally, BofA Securities reiterated a Buy rating with a price target of £39.00, noting a slight increase in full-year 2025 revenue guidance. The trading statement from British American Tobacco highlighted a slight improvement in U.S. combustibles and strong growth in its modern oral product, VELO. However, the company’s vapor performance fell short of expectations, impacting revenue growth in its New Categories segment. Despite this, management remains optimistic about achieving mid-single-digit revenue growth for the full year. Meanwhile, Reynolds American (NYSE:RAI), a subsidiary of British American Tobacco, announced it will discontinue its diversity, equity, and inclusion initiatives, following discussions with activist Robby Starbuck.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.